Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

GUSELKUMAB vs HEPARIN: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

GUSELKUMAB vs HEPARIN: Safety Overview

Metric GUSELKUMAB HEPARIN
Total FAERS Reports 27,987 18,167
Deaths Reported 364 3,150
Death Rate 1.3% 17.3%
Hospitalizations 2,031 7,788
Average Patient Age 52.6 yrs 61.3 yrs
% Female Patients 57.6% 40.0%
FDA Approval Date N/A Approved Prior to Jan 1, 1982
Manufacturer Janssen Biotech, Inc. Sagent Pharmaceuticals
Route SUBCUTANEOUS INTRAVENOUS
Marketing Status Prescription Discontinued